Etiket: Nubeqa
Bayer shares stronger: Bayer receives extended approval for Nubeqa in China
shares in this article The Chinese supervisory authority NMPA gave the green light for the treatment of patients with metastatic hormone-sensitive prostate cancer in combination with androgen deprivation therapy and…
Bayer stock in green: Bayer applies for extended approval for cancer drug Nubeqa in the US and the EU
shares in this article Extended indications for a combination therapy with the Nubeqa active ingredient darolutamide for the treatment of metastatic hormone-sensitive prostate cancer have been requested from the US…